Discovery Health News
- Icy winds, but stunning scenery: Shetland named best place to live Friday, November 21, 2008 @ 8:42PMThey may be 100 miles from the mainland, with biting cold winds, no trees and barely three hours of daylight in the depths of winter, but the Shetland Islands are the best place in Scotland to live, a quality of life survey claimed yesterday.
- Scientists identify blood component that turns bacteria virulent Friday, November 21, 2008 @ 5:47PMScientists from the Scripps Research Institute have discovered the key chemical that signals Bacillus anthracis, the bacterium that causes anthrax, to become lethal. This finding opens up new avenues of exploration for the development of treatments for bacterial infections.
- New Cause Of Fatal Brain Injury From Acute Viral Meningitis Friday, November 21, 2008 @ 5:14PMWhat was once thought to be the culprit responsible for fatal brain damage in acute viral meningitis has now been found to be only an accomplice, say researchers at the Scripps Research Institute.
- Legislature, governor must find $5 billion in spending cuts without raising taxes Friday, November 21, 2008 @ 4:08PMThe state of Washington can cut $5 billion from its 2009-2011 biennial budget if it has to — and it must.
- Professors from China, Brazil, Japan win top medical awards of Thailand Friday, November 21, 2008 @ 3:57PMThe International Award Committee of the Prince Mahidol Award Foundation of Thailand announced Friday three professors from China, Brazil and Japan, respectively, have won its 17th Prince Mahidol Awar...
- Japanese developer of chickenpox vaccine gets award from Thailand+ Friday, November 21, 2008 @ 3:57PMBANGKOK, Nov. 21 (AP) - (Kyodo)—A Japanese virologist who developed the chickenpox vaccine was among three medical researchers who received a royal award from Thailand on Friday for their contrib...
- Researchers report new species of deadly Ebola virus Friday, November 21, 2008 @ 3:40PMNov 21, 2008 (CIDRAP News) – Researchers from the United States and Uganda today released the first full scientific report on a new Ebola species that struck western Uganda late last year and was linked to 149 suspected cases and 37 deaths, at least 4 of them healthcare providers.
- Scripps research scientists identify blood component that turns bacteria virulent Friday, November 21, 2008 @ 2:10PM( Scripps Research Institute ) Scientists from the Scripps Research Institute have discovered the key chemical that signals Bacillus anthracis, the bacterium that causes anthrax, to become lethal. This finding opens up new avenues of exploration for the development of treatments for bacterial infections.
- FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain Friday, November 21, 2008 @ 1:28PM Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option.
- Merrill Corporation Earns Top-Tier Position in Am Law 13th Annual Technology Survey Friday, November 21, 2008 @ 12:54PM ST. PAUL, Minn.----Merrill Corporation, a leading global provider of technology-enabled services for the legal, financial, health care, real estate and other corporate markets, today announced that its electronic data discovery solution, including consulting, forensics investigation, data acquisition, processing and Merrill’s Lextranet® case management and review tool, earned a top-tier ...
- Demolition of Hicksville garage delayed Friday, November 21, 2008 @ 12:19PMThe demolition of the Hicksville parking garage is going to take about two months longer than expected, Oyster Bay town officials said.
- Los Alamos scientists see new mechanism for superconductivity Friday, November 21, 2008 @ 11:51AM( DOE/Los Alamos National Laboratory ) Los Alamos National Laboratory researchers have posited an explanation for superconductivity that may open the door to the discovery of new, unconventional forms of superconductivity.
- Deer head found buried in field Friday, November 21, 2008 @ 10:50AMThe decapitated head of a roe deer is found buried in a Norfolk field by RSPCA vets.
- BioWorld Perspectives Managing Editor Friday, November 21, 2008 @ 10:48AMThe end of 2008 approaches amidst job cuts, a financial crisis and much worry and speculation about the future. Biotech IPOs were almost nonexistent in 2008. Venture funding is down compared to last year. Cutting costs often means cutting jobs.
- Hope against breast cancer Friday, November 21, 2008 @ 8:08AMAMONG Asian countries, the Philippines has the highest prevalence of breast cancer. Since the 1980s, breast cancer ranks number one among the top leading cancers afflicting women and ranks second to lung cancer between both sexes.
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Friday, November 21, 2008 @ 7:52AMMaidenhead, England, November 21 (ots/PRNewswire) - - Not for UK Journalists The European Committee for Medicinal Products for Human Use (CHMP) today ...
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Friday, November 21, 2008 @ 7:43AMMaidenhead, England, November 21 (ots/PRNewswire) - - Not for UK Journalists The European Committee for Medicinal Products for Human Use (CHMP) today announced its positive recommendation for the approval of Enbrel(R) ...
- Can Vitamins and Minerals Prevent Hearing Loss? Friday, November 21, 2008 @ 7:35AMANN ARBOR, Mich. — About 10 million people in the United States alone -- from troops returning from war to students with music blasting through headphones -- are suffering from impairing noise-induced hearing loss.
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Friday, November 21, 2008 @ 7:30AM -
- Collexis Named a Rising Star by Outsell, Inc. Friday, November 21, 2008 @ 7:30AM Collexis Holdings Inc. , a leading developer of semantic search and knowledge discovery software, announced today that Outsell, Inc. has named Collexis as one of its rising stars.
- Empire Genomics signs 2 deals Friday, November 21, 2008 @ 3:52AMTwo new partnerships are expected to boost contracts at a Buffalo life sciences firm.
- Toronto leading the way in stem cell research Friday, November 21, 2008 @ 3:47AMOne year after researchers discovered a major alternative to embryonic stem cells, the remarkable bit of modern-day alchemy is still shaking the scientific world.
- Another outbreak hits Guelph General Friday, November 21, 2008 @ 3:37AMGUELPH (Nov 21, 2008) -- Guelph General Hospital is redoubling visitor restrictions after another outbreak of a contagious virus.
- UC San Diego Health Sciences Announces Collaboration With Johnson & Johnson Pharmaceutical Research & Development Friday, November 21, 2008 @ 1:54AMUniversity of California, San Diego Health Sciences leaders have announced that they have executed a formal Memorandum of Understanding (MOU) with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), with the objective of developing future collaborations in biomedical research and education to advance human health.
- First cases of emerald ash borer found in Aurora Friday, November 21, 2008 @ 12:38AMAURORA – The Illinois Department of Agriculture has confirmed the first cases of emerald ash borer infestation in the city.
- Scientists discover new species of Ebola virus Thursday, November 20, 2008 @ 7:20PMScientists report the discovery of a new species of Ebola virus, provisionally named Bundibugyo ebolavirus, Nov. 21 in the open-access journal PLoS Pathogens. The virus, which was responsible for a hemorrhagic fever outbreak in western Uganda in 2007, has been characterized by a team of researchers from the Centers for Disease Control and Prevention in Atlanta, Ga., the Uganda Virus Research ...
- Link Between Nicotine Addiction And Autism Found Thursday, November 20, 2008 @ 6:39PMScientists have identified a relationship between two proteins in the brain that has links to both nicotine addiction and autism. The finding has led to speculation that existing drugs used to curb nicotine addiction might serve as the basis for potential therapies to alleviate the symptoms of autism. The discovery identified a defining role for a protein made by the neurexin-1 gene, which is ...
- China Announces Food Safety Rules Thursday, November 20, 2008 @ 1:21PMThe Chinese government issued several new measures aimed at reining in abuses in the dairy industry.
- Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin Thursday, November 20, 2008 @ 1:16PMPharmaMar announced today that Ortho Biotech Products, L.P. has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for trabectedin when administered in combination with DOXIL® (pegylated liposomal doxorubicin) for the treatment of women with relapsed ovarian cancer (ROC).
- Home & Garden: Thursday, November 20, 2008 @ 1:14PMIf the terriers and bariffs are torn down, this economy will grow.—G.W. Bush (Heck if I know what a bariff is but if the terriers get torn down, I’m moving to Canada—M.C.)
- Pure insulin-producing cells produced in mouse Thursday, November 20, 2008 @ 12:10PM( Agency for Science, Technology and Research (A*STAR), Singapore ) Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells.
- News 11.19.2008 Thursday, November 20, 2008 @ 11:56AMArray
- Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement Thursday, November 20, 2008 @ 11:20AM AUSTIN, Texas & HONG KONG----Luminex Corporation , the worldwide leader in multiplexed solutions, and Mingyuan Medicare Development Company, a leading supplier of biomedical products in China, today announced the signing of a distribution and supply agreement.
- TaconicArtemis Announces Publication In PNAS: Inducible Gene Silencing In Transgenic Rats Via RNAi Thursday, November 20, 2008 @ 11:17AMTaconicArtemis GmbH, a subsidiary of Taconic today announced the publication of a scientific breakthrough achieved in a collaboration with the Universities Goettingen and Wuerzburg (Germany). For the first time it is now possible to inactivate disease-related genes in an inducible and reversible fashion in transgenic rats as rodent model organisms.
- Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment Thursday, November 20, 2008 @ 2:47AMCork, Ireland, November 20 (ots/PRNewswire) - - Telaprevir Data Presented at AASLD Tibotec BVBA today announced that it has begun enrolling patients in ...
- Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver ... Thursday, November 20, 2008 @ 2:39AMCork, Ireland, November 20 (ots/PRNewswire) - - Nearly 90 Percent of Patients Achieve Undetectable Viral Load in Phase IIa Trial Within 28 Days of Combined Treatment With Standard of Care New clinical data demonstrate the safety and antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) ...
- Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment Thursday, November 20, 2008 @ 2:39AMCork, Ireland, November 20 (ots/PRNewswire) - - Telaprevir Data Presented at AASLD Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease ...
- Um, the gym will totally still be there after you finish that creme brulee. Thursday, November 20, 2008 @ 2:36AMAmerican
- Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver ... Thursday, November 20, 2008 @ 2:30AM New clinical data demonstrate the safety and antiviral activity of TMC435, an investigational protease inhibitor being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus infection.
- Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment Thursday, November 20, 2008 @ 2:30AM Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir , an investigational protease inhibitor , in patients with chronic genotype 1 hepatitis C virus for whom the current standard treatment has not been successful.
- Theater, Dance, Arts Listings 11/20 Thursday, November 20, 2008 @ 2:16AMTHEATER
- Robaks fight county over floodway Wednesday, November 19, 2008 @ 8:59PMDARBY - Although its controversial growth policy was repealed at the ballot box two weeks ago, Ravalli County’s struggle over land-use planning continues to play out on a remote riverbank and in a city courtroom.
- Enzyme Discovery May Lead To Better Heart And Stroke Treatments Wednesday, November 19, 2008 @ 6:10PMA new study sheds new light on the way one of our cell enzymes, implicated in causing tissue damage after heart attacks and strokes, is normally kept under control.
- Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer Wednesday, November 19, 2008 @ 5:57PM Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited , today announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib in combination with paclitaxel and carboplatin for the first-line treatment of advanced non-small cell lung cancer has been temporarily suspended following a planned safety data review of 600 patients by the ...
- Pursuit of knowledge Wednesday, November 19, 2008 @ 5:26PMRecognising women in science.
- Scientists discover new compounds to target muscular dystrophy Wednesday, November 19, 2008 @ 5:25PMUsing a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
- David Kirby: Tom Daschle: Friend to Many Autism Families Wednesday, November 19, 2008 @ 4:32PMSenator Daschle is not anti-vaccine, but his record shows his willingness to question -- and even oppose -- vaccine makers and big pharmaceutical interests when it comes to protecting the rights of American medical consumers. Presented By: Expedition Week Continues Tonight Seven nights of one great discovery after another continues tonight at 9P e/p only on ...
- Young Hungarian researchers receive prestigious Scopus Award Tuesday, November 18, 2008 @ 9:19AM( Elsevier ) The Scopus Young Scientist Awards were awarded to the best young researchers under 30 years old, in ten scientific disciplinary areas.
- Neighbors remember 86-year-old man killed in Raritan Township Tuesday, November 18, 2008 @ 9:14AMIt all started with a pile of newspapers.
- HEALTHY OUTLOOK Tuesday, November 18, 2008 @ 9:12AM[Ray and Jean Churchill, Merrifield, have had a string of mishaps and health issues in the past dozen years that might have sent a lesser couple into a state of self-pity and woe-is-me. And who could blame them? Amazingly, this couple still peppers their conversations with words like "lucky," "blessing" and "thankful."